Otonomy sinks after Otividex fails in late-stage trial for Ménière’s disease
February 22 2021 - 7:53AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Apr 2023 to Apr 2024